about
Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis.Neoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population.Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy.Association of functional -509C>T polymorphism in the TGF-β1 gene with infiltrating ductal breast carcinoma risk in a Russian Western Siberian population.The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen.The effect of folate-related SNPs on clinicopathological features, response to neoadjuvant treatment and survival in pre- and postmenopausal breast cancer patientsImpact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer
P50
Q33991836-71C2D520-2A43-4616-9E83-53E68F297740Q46542099-FBA1E587-4A36-41AC-8877-D70F9038BE25Q48136997-78218D6A-4230-4BB5-B35B-672ACFC58C7BQ51480239-62697BC2-B8DB-40F1-AD2B-B7D1F7332711Q53784002-30ADFC11-87A2-4FD8-9B0B-18C7FC69195EQ85848787-4E2D8D03-EB72-43C9-A6B9-84C90505FA92Q90341044-CC19F848-B1B6-40B0-BFB5-CA7F0BD7BAA2
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Natalija Nikolajewna Babyschkina
@de
Nataliya Babyshkina
@en
Nataliya Babyshkina
@nl
Наталия Николаевна Бабышкина
@ru
type
label
Natalija Nikolajewna Babyschkina
@de
Nataliya Babyshkina
@en
Nataliya Babyshkina
@nl
Наталия Николаевна Бабышкина
@ru
altLabel
Natalija Babyschkina
@de
Nataliya Nikolayevna Babyshkina
@en
prefLabel
Natalija Nikolajewna Babyschkina
@de
Nataliya Babyshkina
@en
Nataliya Babyshkina
@nl
Наталия Николаевна Бабышкина
@ru
P106
P21
P31
P496
0000-0002-0562-3878